ZOETIS INC.

Day range

$80.10 – $81.19

Open

$80.95

Prev close

$81.03

Volume

1.52M

Market cap

$33.48B

Shares out

413.22M

P/E

12.80

P/S

3.52

P/B

10.64

P/FCF

14.15

ROE

83.1%

ROA

17.3%

Debt/Equity

2.87

Div yield

2.66%

As of Oct 23, 2026

• Director appointmentOct 13, 2026

  On October 8, 2026, the Board of Directors (the "Board") of Zoetis Inc. (the "Company") appointed Iris Knobloch to the Board, effective as of December 1, 2026, to serve in such capacity until her successor is appointed or qualified or until her resignation or removal. In connection with the appointment of Ms. Knobloch, the size of the Board will be increased from twelve to thirteen members effective as of December 1, 2026. Ms. Knobloch has been appointed to serve on the Board's Corporate Governance Committee.

• Dividend declarationOct 8, 2026

  On October 8, 2026, the Company declared a dividend of $0.53 per share for the fourth quarter of 2026. The dividend will be paid on December 1, 2026, to all holders of record of the Company's common stock as of the close of business on October 30, 2026.

• Quarterly earningsAug 6, 2026

  On August 6, 2026, Zoetis Inc. (the Company) issued a press release reporting its financial results for the second quarter of 2026 and its guidance for full year 2026.

• Cfo appointmentAug 6, 2026

  James Saccaro has been appointed as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. Mr. Saccaro will lead Zoetis' global finance function, shaping capital allocation, financial strategy, reporting and controls, and investor engagement and oversee Global Manufacturing and Supply to drive operational execution and performance. He will serve as the principal financial officer and principal accounting officer of the Company.

• Annual meeting resultsMay 22, 2026

  As discussed under Item 5.02 of this Current Report on Form 8-K, on May 20, 2026, the Company held the Annual Meeting. At the Annual Meeting, the Company's shareholders voted on five proposals... Each of the twelve nominees for director was elected to serve for a one-year term until the 2027 Annual Meeting of Shareholders.

Days to cover

4.1

Short interest

18.42M

Avg volume

4.5M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
  negativeZacks Investment Research· Oct 23, 2026
• ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?
  neutralZacks Investment Research· Oct 21, 2026
• Europe Companion Animal Diagnostics Market Size and Forecast, 2021 - 2031 | AI-Enabled Testing and Preventive Pet Care Fuel 9.5% CAGR and a US$2.27 Billion Opportunity
  positiveGlobeNewswire Inc.· Oct 21, 2026
• Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
  negativeZacks Investment Research· Oct 9, 2026
• Is it the Right Time to Add Phibro Stock to Your Portfolio?
  positiveZacks Investment Research· Oct 8, 2026